BioSpace News Archive

Biotech Beach

Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024

Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on April 4, 2024.

April 2, 2024
·
3 min read
BioForest

Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Aurion Biotech today announced several presentations during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston, Massachusetts.

April 2, 2024
·
3 min read
Pharm Country

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., will be presenting data on LACRIFILL® Canalicular Gel, a novel therapy for dry eye symptoms, during the American Society of Cataract and Refractive Surgery Annual Meeting in Boston, MA on April 5-8, 2024.

April 2, 2024
·
4 min read
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

LifeTech Scientific Corporation, a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries announced the audited consolidated results for the year ended 31 December 2023.

April 2, 2024
·
13 min read
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024

April 2, 2024
·
3 min read
Pharm Country

Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office

Linnaeus Therapeutics, Inc. today announced that on March 6, 2024 , the European Patent Office (EPO) issued EP patent 3,823,617 (‘617 patent) covering the pharmaceutical composition of matter for the company’s lead compound, LNS8801.

April 2, 2024
·
3 min read
Biotech Beach

EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting

EpicentRx, Inc today announced that an abstract on its lead therapy, AdAPT-001, will be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held in San Diego, CA from April 5-10, 2024.

April 2, 2024
·
2 min read
Neurology Market Expected to Witness Sustained Growth

The global neurology market size was estimated at USD 3.32 billion in 2023 and is projected to hit around USD 6.42 billion by 2032, registering at a CAGR of 7.60% from 2023 to 2032.

April 2, 2024
·
11 min read
Pharm Country

Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later date.

April 2, 2024
·
3 min read
Single-cell Analysis Market Poised for Substantial Growth 18.33%

The single-cell analysis market size was estimated at USD 4.64 billion in 2023 and it is increasing up to USD 24.97 billion by 2033

April 2, 2024
·
13 min read